Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 5,000 shares at $124.64 ($622K) on 2014-11-07, disclosed to the SEC on 2014-11-07.
Scheduled sale ($622k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.10 | 1,400 | $174K | 27.9% |
| 2 | $124.64 | 3,600 | $449K | 72.1% |
| Total | $124.49 avg | 5,000 | $622K | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |